Cargando…

Annual Plasma Neurofilament Dynamics Is a Sensitive Biomarker of Disease Activity in Patients with Multiple Sclerosis

Background and Objectives: Neurofilament light chain (NfL) is a sensitive biomarker of neuroaxonal damage. This study aimed to assess the relationship between the annual change in plasma NfL (pNfL) and disease activity in the past year, as defined by the concept no evidence of disease activity (NEDA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fedičová, Miriam, Mikula, Pavol, Gdovinová, Zuzana, Vitková, Marianna, Žilka, Norbert, Hanes, Jozef, Frigová, Lýdia, Szilasiová, Jarmila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222635/ https://www.ncbi.nlm.nih.gov/pubmed/37241097 http://dx.doi.org/10.3390/medicina59050865

Ejemplares similares

Poor sleep quality in patients with multiple sclerosis: gender differences
por: Vitkova, Marianna, et al.
Publicado: (2016)

Fatigue and Suicidal Ideation in People With Multiple Sclerosis: The Role of Social Support
por: Mikula, Pavol, et al.
Publicado: (2020)

Importance of Retesting for the Final Diagnosis of Post-Stroke Cognitive Impairment
por: Koren, Dominik, et al.
Publicado: (2023)

Lower-limb progressive paraparesis management and diagnosis overview in a pregnant woman with vertebral haemangioma
por: Ridzoňová, Lívia, et al.
Publicado: (2022)

Concomitant occurrence of Wernicke’s encephalopathy and sarcopenia due to vitamin D depletion in patients with alcohol use disorder: a case report
por: Fraenkel, Emil, et al.
Publicado: (2023)

The insomnia phenotype in genetic Creutzfeldt–Jakob disease based on the E200K mutation
por: Feketeova, Eva, et al.
Publicado: (2019)

Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2020)

Novel Diagnostic Tools for Identifying Cognitive Impairment in Dogs: Behavior, Biomarkers, and Pathology
por: Vikartovska, Zuzana, et al.
Publicado: (2021)

Using a State-Bounding Observer to Predict the Guaranteed Limits of Drug Amounts in Rats after Oral Administration Based on an Uncertain Pharmacokinetic Model
por: Vitková, Zuzana, et al.
Publicado: (2022)

Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis
por: Joisten, Niklas, et al.
Publicado: (2021)

Association, Distribution, Liberation, and Rheological Balances of Alkyldimethylbenzylammonium Chlorides (C12–C16) †
por: Vitková, Zuzana, et al.
Publicado: (2017)

The Evolution of Neurofilament Light Chain in Multiple Sclerosis
por: Ferreira-Atuesta, Carolina, et al.
Publicado: (2021)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

The potential of serum neurofilament as biomarker for multiple sclerosis
por: Bittner, Stefan, et al.
Publicado: (2021)

Role of plasma phosphorylated neurofilament heavy chain (pNfH) in amyotrophic lateral sclerosis
por: Zecca, Chiara, et al.
Publicado: (2022)

Commentary
por: Gdovinova, Zuzana
Publicado: (2012)

In-Vivo Analysis and Model-Based Prediction of Tensides’ Influence on Drug Absorption
por: Vitková, Zuzana, et al.
Publicado: (2021)

Robust Control of Repeated Drug Administration with Variable Doses Based on Uncertain Mathematical Model
por: Vitková, Zuzana, et al.
Publicado: (2023)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

Antibodies to neurofilament light as potential biomarkers in multiple sclerosis
por: Puentes, Fabiola, et al.
Publicado: (2021)

Neurofilaments in progressive multiple sclerosis: a systematic review
por: Williams, Thomas, et al.
Publicado: (2020)

Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study
por: Vacchiano, Veria, et al.
Publicado: (2021)

Increased Serum Neurofilament Light and Thin Ganglion Cell–Inner Plexiform Layer Are Additive Risk Factors for Disease Activity in Early Multiple Sclerosis
por: Lin, Ting-Yi, et al.
Publicado: (2021)

Impact of the COVID-19 outbreak on neurological consultation in an emergency department
por: Maretta, Milan, et al.
Publicado: (2022)

Phosphorylation and compactness of neurofilaments in multiple sclerosis: Indicators of axonal pathology()
por: Petzold, Axel, et al.
Publicado: (2008)

Neurofilament Proteins as Body Fluid Biomarkers of Neurodegeneration in Multiple Sclerosis
por: Gresle, Melissa M., et al.
Publicado: (2011)

Serum neurofilament light as a biomarker in progressive multiple sclerosis
por: Kapoor, Raju, et al.
Publicado: (2020)

Serum neurofilament levels and patient‐reported outcomes in multiple sclerosis
por: Galetta, Kristin, et al.
Publicado: (2021)

Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis
por: Kouchaki, Ebrahim, et al.
Publicado: (2021)

Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives
por: Falzone, Yuri Matteo, et al.
Publicado: (2021)

Natalizumab Pharmacokinetics and -Dynamics and Serum Neurofilament in Patients With Multiple Sclerosis
por: Proschmann, Undine, et al.
Publicado: (2021)

Effect of neurofilament analysis on the diagnostic delay in amyotrophic lateral sclerosis
por: De Schaepdryver, Maxim, et al.
Publicado: (2022)

Association of serum neurofilament light with microglial activation in multiple sclerosis
por: Saraste, Maija, et al.
Publicado: (2023)

Comparing Neurofilament Light Chain Levels in Serum and Plasma
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)

Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study
por: Lu, Ching-Hua, et al.
Publicado: (2015)

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
por: Lu, Ching-Hua, et al.
Publicado: (2015)

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
por: Disanto, Giulio, et al.
Publicado: (2017)

Neurofilament light levels are associated with long-term outcomes in multiple sclerosis
por: Kuhle, Jens, et al.
Publicado: (2019)

Blood neurofilament light levels segregate treatment effects in multiple sclerosis
por: Delcoigne, Bénédicte, et al.
Publicado: (2020)

Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
por: Bock, Markus, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ttjtj3rfg95ifptnauibsssg53